Search research articles
Contact Us
Filters
Showing results (31-40 of 167) with videos related to
Page
of 17
Sort By:
The Journal of Pharmacy and Pharmacology
|
January 1, 1981
Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat
A L Gundlach, P M Beart
Neuroscience Letters
|
April 4, 1997
Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor
L D Mercer, P M Beart
Journal of Neurochemistry
|
February 1, 1982
Neurochemical studies of the mesolimbic dopaminergic pathway: glycinergic mechanisms and glycinergic-dopaminergic interactions in the rat ventral tegmentum
A L Gundlach, P M Beart
Trends in Pharmacological Sciences
|
August 1, 1995
Fishing for drugs from the sea: status and strategies
D J de Vries, P M Beart
Brain Research
|
July 1, 1986
Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates
D J de Vries, P M Beart
European Journal of Pharmacology
|
November 20, 1990
[125I][D-Tyr25,Nle28,31]CCK-(25-33): a convenient new aminopeptidase resistant cholecystokinin analogue for radioligand binding and autoradiography
M Carlberg, P M Beart, B Jarrott
European Journal of Pharmacology
|
October 30, 1984
Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations
D J De Vries, P M Beart
British Journal of Pharmacology
|
April 1, 1995
Blockade by polyamine NMDA antagonists related to ifenprodil of NMDA-induced synthesis of cyclic GMP, increases in calcium and cytotoxicity in cultured neurones
P M Beart, A Schousboe, A Frandsen
British Journal of Pharmacology
|
July 3, 2004
Flavonoids: some of the wisdom of sage?
G A R Johnston, P M Beart
Journal of Neurochemistry
|
July 1, 1993
Transport of L-[3H]arginine in cultured neurons: characteristics and inhibition by nitric oxide synthase inhibitors
N Westergaard, P M Beart, A Schousboe
Page
of 17
Search research articles
Search
Showing results (31-40 of 167) with videos related to
Sort By:
Page
of 17
The Journal of Pharmacy and Pharmacology
|
January 1, 1981
Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat
A L Gundlach, P M Beart
Neuroscience Letters
|
April 4, 1997
Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor
L D Mercer, P M Beart
Journal of Neurochemistry
|
February 1, 1982
Neurochemical studies of the mesolimbic dopaminergic pathway: glycinergic mechanisms and glycinergic-dopaminergic interactions in the rat ventral tegmentum
A L Gundlach, P M Beart
Trends in Pharmacological Sciences
|
August 1, 1995
Fishing for drugs from the sea: status and strategies
D J de Vries, P M Beart
Brain Research
|
July 1, 1986
Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates
D J de Vries, P M Beart
European Journal of Pharmacology
|
November 20, 1990
[125I][D-Tyr25,Nle28,31]CCK-(25-33): a convenient new aminopeptidase resistant cholecystokinin analogue for radioligand binding and autoradiography
M Carlberg, P M Beart, B Jarrott
European Journal of Pharmacology
|
October 30, 1984
Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations
D J De Vries, P M Beart
British Journal of Pharmacology
|
April 1, 1995
Blockade by polyamine NMDA antagonists related to ifenprodil of NMDA-induced synthesis of cyclic GMP, increases in calcium and cytotoxicity in cultured neurones
P M Beart, A Schousboe, A Frandsen
British Journal of Pharmacology
|
July 3, 2004
Flavonoids: some of the wisdom of sage?
G A R Johnston, P M Beart
Journal of Neurochemistry
|
July 1, 1993
Transport of L-[3H]arginine in cultured neurons: characteristics and inhibition by nitric oxide synthase inhibitors
N Westergaard, P M Beart, A Schousboe
Page
of 17